Latest News about INCY
Recent news which mentions INCY
MorphoSys' Monjuvi Shows Long-Term Durable Response In Blood Cancer Settings
September 29, 2022
From Benzinga
Important Biotech Catalysts For September 15, 2022 - End Of The Day Summary
September 15, 2022
From Benzinga
20 value stocks whose growth potential is overlooked by investors
September 12, 2022
From MarketWatch
Recap Of Friday's Biotech Catalysts - End Of the Day Summary
August 26, 2022
From Benzinga
Incyte Gets FDA Nod For Hematologic Malignancies Candidate
August 26, 2022
Tickers
INCY
From Benzinga
4 Growth Stocks to Buy and Hold Forever
August 12, 2022
From Motley Fool
Benzinga's Top Ratings Upgrades, Downgrades For August 3, 2022
August 03, 2022
From Benzinga
Biotech Daily: Trial Setback For Eliem Therapeutics, Allarity Drops Work On Cancer Monotherapies, Axcella Aces Long COVID Study
August 02, 2022
From Benzinga
From Benzinga
From Benzinga
From Motley Fool
From Benzinga
From Benzinga
From Benzinga
Twitter And 3 Other Stocks Insiders Are Selling
July 12, 2022
From Benzinga
From Motley Fool
From Benzinga
7 Defensive Stocks to Buy for a Bear Market
June 27, 2022
From InvestorPlace
7 Defensive Stocks to Buy for a Bear Market
June 27, 2022
Tags
NYSE:ADM,NYSE:CPB,NYSE:KO,NYSE:ED,NYSE:LLY,NYSE:KMB,NYSE:LMT,NASDAQ:INCY,NYSE:MKC
CPB
Market News
From InvestorPlace
From Motley Fool
Approval Of Baricitinib For Patchy Baldness Validates Clinical Patch For This Small-Cap Stock
June 14, 2022
From Benzinga
From Benzinga
From Benzinga
Lilly-Incyte Snag FDA Nod For Patchy Hair Loss Treatment — Smaller Rival's Stock Shoots Up In Sympathy
June 14, 2022
From Benzinga
From MarketWatch
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.